Researchers seeking volunteers for COVID-19 vaccine study
Phase III clinical trial to assess if a potential vaccine is effective at preventing symptomatic COVID-19 is now open for enrollment by The University of Texas Health Science Center at Houston (UTHealth) in collaboration with Memorial Hermann-Texas Medical Center.
The study vaccine, AstraZeneca’s AZD1222, has been shown in early-stage human trials to produce a positive immune response. This trial seeks to enroll 30,000 individuals across the nation. The Houston research site is the UTHealth Clinical Research Unit at Memorial Hermann-Texas Medical Center.
November 2, 2020